AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 201 min read$BHC

Lenar Aimee J. sold $259K of BHC

Lenar Aimee J. (President, US Pharma) sold 36,827 shares of Bausch Health Companies Inc. (BHC) at $7.03 ($0.26M total) on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lenar Aimee J.
Published Aug 20, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BHC
Bearish
medium confidence
Mentioned
$BHC
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BHCBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment for BHC.

02

Market read

A senior executive's stock sale adds a modest data point for traders monitoring BHC.

03

What to watch

The insider retains a large stake (334,853 shares) indicating continued confidence.

Relevance 3/10Novelty 5/10Timing: post‑market filing on Aug 20

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$BHCBearishMedium confidence
Context

President of US Pharma sold 36,827 shares for $258,894 via a 10b5‑1 plan.

Expected impact

Potential modest downward pressure on BHC stock.

Evidence & confidence

Sale size is modest relative to holdings but involves a senior executive; market may interpret as a slight bearish signal.

Market effects

Sector

Limited impact on the broader pharma sector.

Regional

No significant regional effect.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

The sale could be routine portfolio rebalancing, not a bearish sign.

Key entities

  • person
    Lenar Aimee J.

    President, US Pharma at Bausch Health Companies.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BHC insider trading history →

Related articles

AUG 10
$BHCMedAI 8/10

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Bausch Health Companies (BHC) shares rose nearly 40% in July after a Canada regulatory update and a beat-and-raise quarter. Prokedi was added to Quebec’s formulary. In Q2, revenue and adjusted results improved, with adjusted EPS $1.26 vs $1.23 expected, and net income $476M. Bausch raised 2026 revenue to $10.79B-$11.04B and adjusted EBITDA to $4.05B-$4.18B.

fool.com6 min
AUG 9
$BHCMedAI 9/10

Bausch Health (BHC) Q2 2026 Earnings Call Transcript

Bausch Health (NYSE:BHC) reported Q2 2026 results excluding Bausch + Lomb: revenue $1.458B (+16%), adjusted EBITDA $865M (+28%), margin 59.3% (+530 bps), and adjusted operating cash flow $471M. Net debt fell to $13.7B. Full-year 2026 guidance was raised. Headwinds include Aplenzin LOE and CMS rebate impacts.

aol.com6 min
AUG 2
$BHCMed

BHC Surges As Bausch Health Crushes Q2 And Lifts 2026 Outlook

Bausch Health Companies Inc. (BHC) shares rose about 13.6% after Q2 results and an improved 2026 outlook, according to the article. Q2 non-GAAP EPS was $1.26 vs $1.01 consensus, revenue $2.85B vs $2.66B. The company reported free cash flow around $593M and lifted 2026 guidance to revenue $10.79B-$11.04B and adjusted EBITDA $4.05B-$4.175B.

stockstotrade.com6 min
AUG 1
$BHCHighAI 9/10

BHC Soars As Bausch Health Earnings Beat Triggers Repricing

Bausch Health Companies Inc. (BHC) shares rose about 13.6% after Q2 results beat expectations and 2026 guidance was raised, according to the article. Q2 revenue was about $2.85B vs $2.66B expected, non-GAAP EPS $1.26 vs $1.01, with $670M operating cash flow and $593M free cash flow. The stock moved from the $4s to near $6.9.

stockstotrade.com6 min